ReviewFrontiers in immunology2024

Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment.

Zhumin Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.